Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.4B
93M shares
52-week range
$11.06 – $17.11
53% from low
Exchange
NYSE
CS
Borrow rate
0.30%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.35B | $2.40B | $2.35B | $2.55B | $2.77B | $2.82B | $2.77B | $2.67B |
| Cost of revenue | $1.73B | $1.77B | $1.75B | $1.90B | $2.10B | $2.14B | $2.12B | $2.05B |
| Gross profit | $626.1M | $638.2M | $595.3M | $650.8M | $674.8M | $678.9M | $645.6M | $621.7M |
| Gross margin | 26.6% | 26.5% | 25.4% | 25.5% | 24.3% | 24.1% | 23.3% | 23.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $40.0M | $129.7M | $12.1M | $90.5M | $88.4M | $101.0M | $156.9M | $134.6M |
| EBITDA | $186.9M | $266.1M | $149.7M | $230.2M | $222.8M | $244.0M | $303.1M | $306.5M |
| Net income | −$15.1M | $44.4M | −$41.6M | $46.3M | $14.0M | −$7.7M | $66.4M | $56.0M |
| Net margin | -0.6% | 1.8% | -1.8% | 1.8% | 0.5% | -0.3% | 2.4% | 2.1% |
| EPS (diluted) | -0.18 | 0.43 | -0.40 | 0.44 | 0.14 | -0.08 | 0.20 | 0.57 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.8B | $0.66 | $0.62–$0.70 | 6 |
| 2027 | $2.8B | $0.74 | $0.67–$0.79 | 6 |
| 2028 | $2.9B | $0.88 | $0.86–$0.89 | 3 |
| 2029 | $3.2B | $0.00 | $0.00–$0.00 | 3 |
Forward consensus · source: Financial Modeling Prep
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.
www.brightview.comNo one on the platform currently holds BV.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-06-30 | 15,000 | $249.8K |
No one on the platform has traded BV yet.
| $1.2B |
| — |
| LMBLimbach Holdings, Inc. | $78.85 | -2.97% | $940M | — |
| LNNLindsay Corporation | $124.23 | -0.50% | $1.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at NaN× earnings vs its 50.5× historical median P/E.
Fair value ≈ $-6.40 · price $14.27 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$BV monthly: gearing up for a break out and a monster run. 42% upside potential if November 2024 highs draw liquidity.
View on StockTwits ↗https://marketbeat.com/a/8644361/ $BV BrightView Q2 Earnings Call Highlights
View on StockTwits ↗$BV Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.08 down -166.67% YoY • Reported revenue of $702.9M up 6.08% YoY
View on StockTwits ↗$BV Share Price: $11.76 Contract Selected: Oct 16, 2026 $15 Calls Buy Zone: $0.73 – $0.90 Target Zone: $1.19 – $1.45 Potential Upside: 54% ROI Time to Expiration: 167 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$BV hit all my 10 indicators so I bought a small pisition. Small, scarred investors. This is for you.
View on StockTwits ↗$BV BrightView Holdings provides landscaping services. Demand tied to commercial spending. Margins improve with scale.
View on StockTwits ↗$BV is a biotech company (Bioventus) focused on orthobiologics and regenerative medicine; it is navigating commercial execution challenges and a heavy debt load.
View on StockTwits ↗$BV Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.26 down -30.00% YoY • Reported revenue of $614.7M up 2.59% YoY • BrightView reaffirms its fiscal year 2026 guidance, expecting total revenue between $2.670 billion and $2.730 billion, with Adjusted EBITDA projected to be $363 million to $377 million, representing 40 to 60 basis points margin expansion.
View on StockTwits ↗$PLTR $CRWD $BV $TSLA $SCAM.X more wars and distraction this week.
View on StockTwits ↗Morgan Stanley has updated their rating for BrightView Hldgs ( $BV ) to Equal-Weight with a price target of 13.
View on StockTwits ↗Morgan Stanley has adjusted their stance on BrightView Hldgs ( $BV ), setting the rating to Equal-Weight with a target price of 16 → 12.
View on StockTwits ↗Goldman Sachs has adjusted their stance on BrightView Hldgs ( $BV ), setting the rating to Sell with a target price of 13.5 → 10.5.
View on StockTwits ↗$BV https://anachart.com/wp-content/uploads/ana_temp/1763730120_soc-img.jpg
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.